We used MAGEA12 as an additional “negative” control because MAGEA12 is a cancer-testis antigen and the expression of MAGEA12 causes increases in cell proliferation [6]; furthermore, MAGEA12 shares only 39% sequence identity with MAGEB2. Here, MAGEB2 is linked to cancer.